354 related articles for article (PubMed ID: 28549786)
1. Action potential-based MEA platform for in vitro screening of drug-induced cardiotoxicity using human iPSCs and rat neonatal myocytes.
Jans D; Callewaert G; Krylychkina O; Hoffman L; Gullo F; Prodanov D; Braeken D
J Pharmacol Toxicol Methods; 2017 Sep; 87():48-52. PubMed ID: 28549786
[TBL] [Abstract][Full Text] [Related]
2. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
Kitaguchi T; Moriyama Y; Taniguchi T; Maeda S; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Miyamoto N
J Pharmacol Toxicol Methods; 2017; 85():73-81. PubMed ID: 28163191
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers.
Goineau S; Castagné V
J Pharmacol Toxicol Methods; 2018; 90():58-66. PubMed ID: 29274391
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes Using Multielectrode Array.
Bai S; Pei J; Chen K; Zhao Y; Cao H; Tian L; Ma Y; Dong H
SLAS Discov; 2021 Mar; 26(3):364-372. PubMed ID: 32914673
[TBL] [Abstract][Full Text] [Related]
5. The assessment of electrophysiological activity in human-induced pluripotent stem cell-derived cardiomyocytes exposed to dimethyl sulfoxide and ethanol by manual patch clamp and multi-electrode array system.
Hyun SW; Kim BR; Hyun SA; Seo JW
J Pharmacol Toxicol Methods; 2017 Sep; 87():93-98. PubMed ID: 28377112
[TBL] [Abstract][Full Text] [Related]
6. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.
Navarrete EG; Liang P; Lan F; Sanchez-Freire V; Simmons C; Gong T; Sharma A; Burridge PW; Patlolla B; Lee AS; Wu H; Beygui RE; Wu SM; Robbins RC; Bers DM; Wu JC
Circulation; 2013 Sep; 128(11 Suppl 1):S3-13. PubMed ID: 24030418
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive in vitro cardiac safety assessment using human stem cell technology: Overview of CSAHi HEART initiative.
Takasuna K; Asakura K; Araki S; Ando H; Kazusa K; Kitaguchi T; Kunimatsu T; Suzuki S; Miyamoto N
J Pharmacol Toxicol Methods; 2017; 83():42-54. PubMed ID: 27646297
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
Lee HA; Hyun SA; Byun B; Chae JH; Kim KS
PLoS One; 2018; 13(4):e0195577. PubMed ID: 29630634
[TBL] [Abstract][Full Text] [Related]
10. Human and murine embryonic stem cell-derived cardiomyocytes serve together as a valuable model for drug safety screening.
Liang H; Matzkies M; Schunkert H; Tang M; Bonnemeier H; Hescheler J; Reppel M
Cell Physiol Biochem; 2010; 25(4-5):459-66. PubMed ID: 20332627
[TBL] [Abstract][Full Text] [Related]
11. Improving reliability and reducing costs of cardiotoxicity assessments using laser-induced cell poration on microelectrode arrays.
Iachetta G; Colistra N; Melle G; Deleye L; Tantussi F; De Angelis F; Dipalo M
Toxicol Appl Pharmacol; 2021 May; 418():115480. PubMed ID: 33689843
[TBL] [Abstract][Full Text] [Related]
12. Proarrhythmic risk assessment using conventional and new in vitro assays.
Goineau S; Castagné V
Regul Toxicol Pharmacol; 2017 Aug; 88():1-11. PubMed ID: 28506844
[TBL] [Abstract][Full Text] [Related]
13. Application of optical action potentials in human induced pluripotent stem cells-derived cardiomyocytes to predict drug-induced cardiac arrhythmias.
Lu HR; Hortigon-Vinagre MP; Zamora V; Kopljar I; De Bondt A; Gallacher DJ; Smith G
J Pharmacol Toxicol Methods; 2017 Sep; 87():53-67. PubMed ID: 28501647
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vitro models of stem cell-derived cardiomyocytes to screen for potential cardiotoxicity of chemicals.
Shi M; Tien NT; de Haan L; Louisse J; Rietjens IMCM; Bouwmeester H
Toxicol In Vitro; 2020 Sep; 67():104891. PubMed ID: 32446838
[TBL] [Abstract][Full Text] [Related]
15. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes.
Caspi O; Itzhaki I; Kehat I; Gepstein A; Arbel G; Huber I; Satin J; Gepstein L
Stem Cells Dev; 2009; 18(1):161-72. PubMed ID: 18510453
[TBL] [Abstract][Full Text] [Related]
16. Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform.
Qu Y; Vargas HM
Toxicol Sci; 2015 Sep; 147(1):286-95. PubMed ID: 26117837
[TBL] [Abstract][Full Text] [Related]
17. In silico assessment of the effects of various compounds in MEA/hiPSC-CM assays: Modeling and numerical simulations.
Abbate E; Boulakia M; Coudière Y; Gerbeau JF; Zitoun P; Zemzemi N
J Pharmacol Toxicol Methods; 2018; 89():59-72. PubMed ID: 29066291
[TBL] [Abstract][Full Text] [Related]
18. Predicting cardiac safety using human induced pluripotent stem cell-derived cardiomyocytes combined with multi-electrode array (MEA) technology: A conference report.
Mulder P; de Korte T; Dragicevic E; Kraushaar U; Printemps R; Vlaming MLH; Braam SR; Valentin JP
J Pharmacol Toxicol Methods; 2018; 91():36-42. PubMed ID: 29355722
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity screening of illicit drugs and new psychoactive substances (NPS) in human iPSC-derived cardiomyocytes using microelectrode array (MEA) recordings.
Zwartsen A; de Korte T; Nacken P; de Lange DW; Westerink RHS; Hondebrink L
J Mol Cell Cardiol; 2019 Nov; 136():102-112. PubMed ID: 31526813
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte functional screening: interrogating comparative electrophysiology of high-throughput model cell systems.
Wells SP; Waddell HM; Sim CB; Lim SY; Bernasochi GB; Pavlovic D; Kirchhof P; Porrello ER; Delbridge LMD; Bell JR
Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1256-C1267. PubMed ID: 31577512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
